Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals SBC expense by award type
SBC expense by award type — Restricted stock units (RSUs) & performance stock units (PSUs) ($M) ($M)
Vertex Pharmaceuticals SBC expense by award type: $672M in FY2025, down 2.5% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Note (Stock-based Compensation).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | SBC expense by award type — Restricted stock units (RSUs) & performance stock units (PSUs) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 672 | -2.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 689 | +22.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 564 | +23.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 456 | +18.7% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 384 | +6.6% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 360 | – | Form 10-K (filed 2023-02-10) ↗ |
Breakdown
What makes up SBC expense by award type
Cite this data
StockData. (2026). Vertex Pharmaceuticals SBC expense by award type ($M), annual FY2020–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-by-type-rsu
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.